These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 25390138)

  • 1. Perspective: thinking beyond survival.
    DeBaun MR
    Nature; 2014 Nov; 515(7526):S16. PubMed ID: 25390138
    [No Abstract]   [Full Text] [Related]  

  • 2. Sickle cell disease: time for a closer look at treatment options?
    Sheth S; Licursi M; Bhatia M
    Br J Haematol; 2013 Aug; 162(4):455-64. PubMed ID: 23772687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exchange blood transfusion compared with simple transfusion for first overt stroke is associated with a lower risk of subsequent stroke: a retrospective cohort study of 137 children with sickle cell anemia.
    Hulbert ML; Scothorn DJ; Panepinto JA; Scott JP; Buchanan GR; Sarnaik S; Fallon R; Chu JY; Wang W; Casella JF; Resar L; Berman B; Adamkiewicz T; Hsu LL; Smith-Whitley K; Mahoney D; Woods G; Watanabe M; DeBaun MR
    J Pediatr; 2006 Nov; 149(5):710-2. PubMed ID: 17095350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of sickle cell disease from a life-threatening disease of children to a chronic disease of adults: The last 40 years.
    Chaturvedi S; DeBaun MR
    Am J Hematol; 2016 Jan; 91(1):5-14. PubMed ID: 26547630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia.
    Miller ST; Wright E; Abboud M; Berman B; Files B; Scher CD; Styles L; Adams RJ;
    J Pediatr; 2001 Dec; 139(6):785-9. PubMed ID: 11743502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease.
    Adams RJ; Brambilla D;
    N Engl J Med; 2005 Dec; 353(26):2769-78. PubMed ID: 16382063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventing stroke among children with sickle cell anemia: an analysis of strategies that involve transcranial Doppler testing and chronic transfusion.
    Mazumdar M; Heeney MM; Sox CM; Lieu TA
    Pediatrics; 2007 Oct; 120(4):e1107-16. PubMed ID: 17768181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lifespan care in SCD: Whom to transition, the patients or the health care system?
    Minniti CP; Vichinsky E
    Am J Hematol; 2017 Jun; 92(6):487-489. PubMed ID: 28211097
    [No Abstract]   [Full Text] [Related]  

  • 9. The United States has lower life expectancy than other developed nations, despite having highest health care costs.
    Beller GA
    J Nucl Cardiol; 2013 Apr; 20(2):177-8. PubMed ID: 23436137
    [No Abstract]   [Full Text] [Related]  

  • 10. Feasibility and efficacy of chronic transfusion for stroke prevention in children with sickle cell disease.
    Mirre E; Brousse V; Berteloot L; Lambot-Juhan K; Verlhac S; Boulat C; Dumont MD; Lenoir G; de Montalembert M
    Eur J Haematol; 2010 Mar; 84(3):259-65. PubMed ID: 19912310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventing stroke in sickle cell anemia.
    Platt OS
    N Engl J Med; 2005 Dec; 353(26):2743-5. PubMed ID: 16382060
    [No Abstract]   [Full Text] [Related]  

  • 12. Chronic transfusion therapy for stroke in sickle cell disease.
    DeBaun MR; Quirolo K
    J Clin Apher; 2017 Oct; 32(5):368-370. PubMed ID: 28168723
    [No Abstract]   [Full Text] [Related]  

  • 13. Quality of life among children with sickle cell disease receiving chronic transfusion therapy.
    Stegenga KA; Ward-Smith P; Hinds PS; Routhieaux JA; Woods GM
    J Pediatr Oncol Nurs; 2004; 21(4):207-13. PubMed ID: 15490865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased cerebral blood flow velocity in children with sickle cell disease: adenotonsillectomy or transfusion regimens?
    Bader-Meunier B; François M; Verlhac S; Elmaleh M; Ithier G; Benkerrou M
    Pediatrics; 2007 Jul; 120(1):235-6; author reply 236-7. PubMed ID: 17606584
    [No Abstract]   [Full Text] [Related]  

  • 15. Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease.
    Griessenauer CJ; Lebensburger JD; Chua MH; Fisher WS; Hilliard L; Bemrich-Stolz CJ; Howard TH; Johnston JM
    J Neurosurg Pediatr; 2015 Jul; 16(1):64-73. PubMed ID: 25837886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five-year retrospective study of hospitalization and treatment of patients with sickle cell anemia.
    Tetrault SM; Scott RB
    South Med J; 1976 Oct; 69(10):1314-6. PubMed ID: 982108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sickle cell disease in France in 2008. Achievements and challenges].
    Bégué P
    Bull Acad Natl Med; 2008 Oct; 192(7):1339-47. PubMed ID: 19445360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Avoiding admission for afebrile pediatric sickle cell pain: pain management methods.
    Dumaplin CA
    J Pediatr Health Care; 2006; 20(2):115-22; quiz 123-5. PubMed ID: 16522488
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of long-term transfusion on growth in children with sickle cell anemia: results of the STOP trial.
    Wang WC; Morales KH; Scher CD; Styles L; Olivieri N; Adams R; Brambilla D;
    J Pediatr; 2005 Aug; 147(2):244-7. PubMed ID: 16126058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility and benefit of hydroxycarbamide as a long-term treatment for sickle cell disease patients: results from the North West London Sickle Cell Disease Registry.
    Gilmore A; Cho G; Howard J; Layton M; Afif M; Hughes RG; Philpott NJ; Patankar S; Davies SC;
    Am J Hematol; 2011 Nov; 86(11):958-61. PubMed ID: 21948113
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.